Raltitrexed in the treatment of elderly patients with advanced colorectal cancer: an active and low toxicity regimen
- 30 June 2002
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (9), 1204-1211
- https://doi.org/10.1016/s0959-8049(02)00005-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Comorbidity and colorectal cancer according to subsite and stage: a population-based studyEuropean Journal Of Cancer, 2000
- Should chemotherapy be used as a treatment of advanced colorectal carcinoma (ACC) in patients over 70 years of age?: Contra:European Journal Of Cancer, 1999
- Survival of colorectal cancer patients in Europe during the period 1978–1989European Journal Of Cancer, 1998
- Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle numberEuropean Journal Of Cancer, 1998
- Substantial variation in therapy for colorectal cancer across Europe: EUROCARE analysis of cancer registry data for 1987European Journal Of Cancer, 1996
- ‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopeniaEuropean Journal Of Cancer, 1995
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960